Impact of Chronic Disease Control and Aging Psychology on Outcomes of Frailty-Sarcopenia Syndrome in Ambulatory Geriatric Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02160093

Enrollment

151

Registered

2014-06-10

Start date

2014-06-30

Completion date

2016-08-31

Last updated

2016-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ambulatory Geriatric Outpatients at High Risk of Frailty

Keywords

sarcopenia, frailty, chronic disease control, aging psychology

Brief summary

Pursuant to our previous longitudinal study (ClinicalTrials.gov ID: NCT02073370) in geriatric outpatients cooperated with the Department of Family Medicine, Department of Geriatrics and Gerontology, National Taiwan University Hospital, this study will be conducted to examine the impacts of the specific co-morbidities and ageing psychology on the outcomes of frailty/sarcopenia syndrome. The thresholds of specific chronic disease will be reviewed after frailty being considered in the elderly with co-morbidity condition. In addition, the conceptual framework and corresponding measuring instrument of mental frailty will be expected developed.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

: compatible one of following conditions * functional decline in recent one year * cognitive function decline * depressive symptom * mobility impairment * fall in recent one year * eating or feeding problems/weight loss * co-morbid conditions≧5 * tracking by different physician ≧3 in recent half year * polypharmacy≧8 in recent 3 months * hospitalization ≧1 in recent one year * emergency visits≧2 in recent one year * aged ≧ 80

Exclusion criteria

* non-ambulatory (bed-ridden) patients * long-term residents at nursing homes * patients with a life expectancy shorter than six months * impairment in vision, hearing, or communicative ability * making convenience of clinical evaluation during the study period impossible.

Design outcomes

Primary

Measure	Time frame	Description
Operation instrument of mental frailty for older adults	Up to 2 years	The psychological adaptation to aging is a dynamic process. The dynamic process and the Selection-Optimization-Compensation process will have their effect on the actual coping actions in everyday life. The instruments will be set up to evaluate the aging psychology process

Secondary

Measure	Time frame	Description
Compare the well chronic disease control and inappropriate condition on the dynamic frail transitions in ambulatory geriatric outpatients	up to 4 years	The records of chronic disease control status of the same ambulatory geriatric outpatients from previous study, Clinical evaluation, biomarkers and metabolomics of sarcopenia in frail older adults at ambulatory clinics, will be linked to this study.

Countries

Taiwan

Outcome results